Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

BACKGROUND: Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. T...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Oo, Khine Kyaw, Kamolhan, Thanpawee, Soni, Anish, Thongchot, Suyanee, Mitrpant, Chalermchai, O-charoenrat, Pornchai, Thuwajit, Chanitra, Thuwajit, Peti
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807878/
https://ncbi.nlm.nih.gov/pubmed/33446140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07761-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky